Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies-Reference-Cited by-同舟云学术

Anti-CD25 monoclonal antibody (basiliximab) for prevention of graft-versus-host disease after haploidentical bone marrow transplantation for hematological malignancies

Published:2005-06-20 Issue:4 Volume:36 Page:349-354
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ji S-Q,Chen H-R,Yan H-M,Wang H-X,Liu J,Zhu P-y,Xiao M-h,Xun C-Q

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705046.pdf

Reference39 articles.

1. Henslee-Downey PJ . Choosing an alternative bone marrow donor among available family members. Am J Pediatr Hematol Oncol 1993; 15: 150–161.

2. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. New Engl J Med 1985; 313: 765–771.

3. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. New Engl J Med 1989; 320: 197–204.

4. Deeg HJ, Spitzer TR, Cottler-Fax M et al. Conditioning-related toxicity and acute GVHD in patients given methotrexate/cyclosporine prophylaxis. Bone Marrow Transplant 1991; 7: 193–198.

5. Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide or cyclophosphamide conditioning on inflammatory cytokine release in H-2 incompatible transplanted SCID mice. Blood 1994; 83: 2360–2367.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haploidentical HCT;The EBMT Handbook;2024

2. Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia;Frontiers in Immunology;2022-11-15

3. Infusion of haploidentical HSCs combined with allogenic MSCs for the treatment of ALL patients;Bone Marrow Transplantation;2022-04-25

4. Infusion of haploidentical hematopoietic stem cells combined with mesenchymal stem cells for treatment of severe aplastic anemia in adult patients yields curative effects;Cytotherapy;2022-02

5. HLA-Haploidentical Family Donors: The New Promise for Childhood Acute Lymphoblastic Leukaemia?;Frontiers in Pediatrics;2022-01-21